All In MedTech

Device Trial Radar · NCT03459365

Euflexxa for the Treatment of Osteoarthritis

A Prospective Pilot Study to Evaluate Efficacy and Safety of Euflexxa for the Treatment of Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Sep 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Jul 9, 2018

Primary completion

Sep 30, 2021

Study completion Oct 31, 2021

Sponsor

Lead sponsor
The Cleveland ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 8, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The effect of Euflexxa therapy for knee osteoarthritis on levels of inflammatory and degenerative synovial fluid bio-markers in patients with knee osteoarthritis

Conditions

  • Osteo Arthritis Knee

Interventions

  • EuflexxaDevice

    Aspirations performed before each injection and at six weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Hyaluronate ConcentrationTime frame: Baseline to 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cleveland Clinic

    Cleveland, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.